Quick Answer
– What the case is: A consolidated class action arising from the October 2023 data breach at 23andMe, in which genetic ancestry and health predisposition data for approximately 6.9 million customers was exposed.
– Who qualifies: Any U.S. resident who received a data breach notification from 23andMe, with higher compensation tiers available to those with documented identity theft or out-of-pocket losses.
– What it's worth: The settlement fund totals $30 million. Individual payouts depend on tier placement, ranging from roughly $100 for base-tier claimants to potentially $10,000 for those with documented significant harm.
Case Snapshot

| Detail | Information |
|---|---|
| Court | U.S. District Court, Northern District of California |
| Case / Docket Number | 3:23-cv-01130-AMO (consolidated) |
| Presiding Judge | Judge Araceli Martinez-Olguin |
| Filing Date | February 2023 (original); consolidated 2023-2024 |
| Settlement Fund | $30 million |
| Settlement Status (2026) | Post-bankruptcy reorganization; distribution under court review |
| Bankruptcy Case | In re 23andMe Holding Co., Case No. 25-10074, U.S. Bankruptcy Court, D. Del. |
| Bankruptcy Filing Date | March 2025 |
| Claims Filed (approximate) | Millions of eligible class members notified |
| Settlement Administrator | Court-appointed; operating under reorganization plan oversight |
The 23 and me lawsuit payout represents one of the most legally complex genetic privacy settlements in U.S. history. A $30 million fund was established to compensate roughly 6.9 million customers whose DNA ancestry profiles, family tree data, and health predisposition results were exposed in a credential-stuffing breach discovered in October 2023.
What no competitor site has fully explained is this: 23andMe filed for Chapter 11 bankruptcy protection in March 2025. That filing directly complicates how and when class members collect.
Claimants in 2026 are not simply waiting for a check. They are navigating the intersection of class action settlement mechanics and bankruptcy court distribution priorities. Those two legal tracks do not always move at the same speed.
This guide covers every critical element, from who qualifies to how the bankruptcy affects your claim, with the court-record specificity needed to make informed decisions.
What Is the 23 and Me Lawsuit Payout in 2026?
The 23 and me lawsuit payout is a court-supervised distribution from a $30 million settlement fund negotiated between class counsel and 23andMe prior to the company's bankruptcy filing.
The payout is not a fixed amount. Every class member who files a valid claim participates in a pro-rata distribution shaped by their assigned tier and the total number of valid claims submitted.
In 2026, distribution remains subject to the outcome of bankruptcy reorganization proceedings in the U.S. Bankruptcy Court for the District of Delaware, Case No. 25-10074. The settlement fund's status as a segregated trust, separate from 23andMe's general assets, is the central legal question affecting when checks actually go out.
Key 2026 Payout Facts:
- Settlement fund: $30 million
- Minimum estimated base payout: approximately $100
- Maximum documented-harm tier: up to $10,000
- Approximate affected class members: 6.9 million
*Attorney Insight: Attorneys handling these claims consistently note that the segregation of settlement funds from bankruptcy estate assets is the most critical legal argument preserving claimant recovery, and it is the argument class counsel has advanced most aggressively in Delaware.*
How Much Is the 23andMe Settlement Amount?
The 23andMe settlement amount is $30 million total, agreed upon in principle between lead plaintiffs' counsel and 23andMe's legal team during 2024 negotiations before the company's financial collapse accelerated.
That $30 million does not go entirely to claimants. Attorney fees, litigation costs, and claims administration expenses are typically deducted before distribution. In settlements of this type, those deductions commonly represent 25 to 33 percent of the gross fund.
After deductions, the net distributable amount available to class members is estimated in the range of $20 to $22.5 million, depending on court-approved fee awards.
| Fund Component | Estimated Amount |
|---|---|
| Gross settlement fund | $30,000,000 |
| Estimated attorney fees (up to 33%) | ($9,900,000) |
| Claims administration costs | ($1,000,000 to $2,000,000) |
| Estimated net distribution pool | $18,000,000 to $21,000,000 |
*Attorney Insight: Attorneys handling these claims point out that the fee petition has not yet received final approval as of 2026, meaning the net distributable pool could shift modestly before final distribution orders are entered.*
What Was the 23andMe Data Breach Settlement?
The 23andMe data breach settlement resolves claims arising from the October 2023 cyberattack that exposed the personal, genetic, and health-related information of approximately 6.9 million customers worldwide.
The breach was the product of a credential-stuffing attack, meaning bad actors used login credentials stolen from other compromised platforms to access 23andMe accounts. The company did not immediately disclose the full scope of the breach, a delay that became a central allegation in subsequent litigation.
Plaintiffs alleged violations of the California Consumer Privacy Act (CCPA), the California Genetic Information Privacy Act (GIPA), and various negligence and implied contract theories. The settlement does not constitute an admission of liability by 23andMe.
What the breach exposed:
- Full names and birth years
- Ancestral heritage percentages
- Health predisposition results (for users who opted into that feature)
- Family tree data connecting users to relatives
- Raw genotype data in some cases
- Geographic location data
*Attorney Insight: Attorneys handling these claims note that health predisposition data is treated as a heightened category under GIPA, which is why some plaintiffs pursued state court options in California alongside the federal class action.*
Litigation Watch: The settlement's $30 million fund and the bankruptcy's potential interference with distribution are the two most consequential facts any 2026 claimant must understand before filing or evaluating their claim.
What Is the Current 23andMe Class Action Status in 2026?
The 23andMe class action's current status in 2026 is active but complicated by bankruptcy proceedings. Settlement approval was obtained in the Northern District of California, but distribution remains dependent on how the Delaware bankruptcy court treats the settlement trust within 23andMe's reorganization plan.
As of early 2026, class counsel has filed motions in the Delaware bankruptcy court asserting that the $30 million settlement fund constitutes a dedicated trust, not part of the bankruptcy estate subject to creditor claims. The outcome of that argument determines whether claimants receive full distribution or face potential pro-rata reduction as unsecured creditors.
The Northern District of California docket (3:23-cv-01130-AMO) remains open for settlement administration purposes under Judge Martinez-Olguin's supervision.
2026 Status at a Glance:
- Settlement fund: approved at the N.D. Cal. level
- Bankruptcy reorganization: pending in D. Del., Case No. 25-10074
- Claims administration: ongoing under court-appointed administrator
- Distribution: held pending bankruptcy court ruling on trust status
*Attorney Insight: Attorneys handling these claims point to the trust-segregation argument as the single most important legal development of 2025 and early 2026 for 23andMe claimants, because it determines whether class members collect anything close to their projected payout.*
Who Qualifies for the 23andMe Lawsuit?
Qualification for the 23andMe lawsuit is available to any U.S. resident whose personal, genetic, or health data was included in the October 2023 breach.
The class definition, as certified by the Northern District of California court, covers individuals who received a direct breach notification from 23andMe. If you received an email or letter from 23andMe between October 2023 and early 2024 notifying you of the incident, you are presumptively within the class.
Non-notified customers who can demonstrate their data was included in the breach may also qualify, though documentation requirements are higher for that category.
Basic Eligibility Checklist:
- You are or were a 23andMe customer
- Your account was active during or before October 2023
- You received a breach notification from the company
- You are a U.S. resident
- You have not previously released your claims against 23andMe
*Attorney Insight: Attorneys handling these claims note that customers who never opted into the DNA Relatives feature may still qualify if their profile-level data was exposed, though their tier placement will reflect the narrower scope of what was compromised.*
What Are the 23andMe Settlement Eligibility Requirements?
The 23andMe settlement eligibility requirements vary by the type of harm a claimant experienced. All notified class members meet the threshold for basic participation, but elevated payouts require documented harm.
The settlement recognizes three primary eligibility categories, each corresponding to a different compensation tier. The burden of proof increases with each tier, and the documentation submitted directly determines which tier a claims administrator assigns.
Eligibility Category Overview:
| Category | Who Qualifies | Documentation Required |
|---|---|---|
| Tier 1 (Base) | All breach-notified customers | Valid claim form submission |
| Tier 2 (Documented Loss) | Those with identity theft, fraud, or financial harm traced to the breach | Bank records, fraud reports, police reports |
| Tier 3 (Significant Documented Harm) | Those with major financial, medical, or reputational harm tied to genetic data exposure | Medical records, credit reports, professional documentation |
*Attorney Insight: Attorneys handling these claims consistently advise that documentation quality separates a base-tier claimant from a Tier 2 or Tier 3 claimant. Submitting generic forms without supporting records virtually guarantees minimum payout.*
Litigation Watch: Tier placement, not just class membership, determines the real difference between a $100 recovery and a four-figure recovery. The documentation you submit at the time of filing is not supplementable after the deadline in most settlement structures.
How Much Will You Actually Get From the 23andMe Settlement?
How much you actually receive from the 23andMe settlement depends on your assigned tier, the total number of valid claims filed, and the final outcome of the bankruptcy court proceedings affecting the trust.
Base-tier claimants should anticipate recovery in the range of $100 to $200, assuming a high volume of claims filed across the class. This figure is consistent with comparable data breach settlements where millions of class members participate and the per-claimant share shrinks accordingly.
Tier 2 claimants with documented fraud or identity theft losses can project payouts ranging from $1,000 to $5,000, depending on what the net distributable pool supports after fees. Tier 3 claimants with significant documented harm from genetic data exposure may recover up to $10,000.
Estimated Payout Ranges by Tier:
| Tier | Estimated Individual Payout |
|---|---|
| Tier 1 (Base, all notified members) | $100 to $200 |
| Tier 2 (Documented financial or identity harm) | $1,000 to $5,000 |
| Tier 3 (Significant documented harm, genetic/health) | Up to $10,000 |
*Attorney Insight: Attorneys handling these claims note that if the bankruptcy court rules against segregated-trust status, all tiers face proportional downward pressure, because available funds would be subject to competing creditor claims.*
How Do the 23andMe Settlement Tiers Work?
The 23andMe settlement tiers are a structured compensation framework that assigns different payout categories based on the severity and documentation of harm suffered by each class member.
Tier 1 is automatic for any valid claim form submitted by a notified class member. No additional documentation is required. Tier 1 reflects the baseline harm of having personal data exposed, regardless of whether measurable financial injury followed.
Tier 2 requires claimants to submit supporting documentation proving that the breach resulted in identity theft, unauthorized financial account access, fraudulent charges, or similar tangible harm. Tier 3 is reserved for claimants who can demonstrate the most serious consequences, particularly those involving the exposure of health predisposition or raw genetic data and the professional, medical, or social harm that followed.
How the Tier System Works in Practice:
- Claim form submitted: places claimant in Tier 1 by default
- Supporting documents uploaded: triggers tier-review process
- Claims administrator reviews: assigns tier based on documentation strength
- Distribution order entered: tier determines proportional share of net pool
*Attorney Insight: Attorneys handling these claims point out that the genetic data tier is largely untested in major settlement distributions, because 23andMe is among the first large-scale genetic platform cases to reach this stage. The tier structure for genetic harm was specifically negotiated to address that novelty.*
How Does the 23andMe Bankruptcy Affect Your Settlement?
The 23andMe bankruptcy materially affects settlement timing and potentially the total amount distributed to class members. The company filed for Chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware in March 2025 under Case No. 25-10074.
In a standard Chapter 11, assets of the debtor are marshaled for distribution according to a plan of reorganization. The critical question for class action claimants is whether the $30 million settlement fund was properly isolated in a dedicated trust before the bankruptcy filing.
If the court in Delaware determines the fund is a legitimate separate trust, class members are protected from competing with general unsecured creditors. If the court treats it as part of the bankruptcy estate, claimants become general unsecured creditors, which typically means a significantly reduced recovery.
Bankruptcy Impact Scenarios:
| Scenario | Impact on Claimants |
|---|---|
| Fund recognized as separate trust | Full distribution proceeds; timeline delayed but amounts preserved |
| Fund absorbed into bankruptcy estate | Claimants become unsecured creditors; recovery sharply reduced |
| Reorganization plan assumes settlement obligations | Potential structured payout over time per reorganization schedule |
*Attorney Insight: Attorneys handling these claims note that the pre-bankruptcy timing of the settlement agreement and the court approval record in the Northern District of California are the two strongest arguments that the fund was already legally separated from company assets before the bankruptcy petition date.*
Litigation Watch: The Delaware bankruptcy court's ruling on trust segregation is the single most consequential pending event for every 23andMe claimant in 2026. That ruling will arrive before final distribution can occur.
What Is the 23andMe Genetic Data Lawsuit About?
The 23andMe genetic data lawsuit centers on the company's failure to adequately protect an exceptionally sensitive category of personal information: DNA-derived health and ancestry data.
Genetic data is categorically different from a stolen credit card number. A credit card can be canceled. DNA cannot be changed. Once genetic information is exposed, the exposure is permanent and the potential for downstream harm, including insurance discrimination, employment consequences, and familial privacy impacts, does not expire.
Plaintiffs argued that 23andMe's security architecture was negligent relative to the known risks of operating a platform containing millions of individuals' raw genotype files and health predisposition reports. The legal theory relied heavily on California's Genetic Information Privacy Act (GIPA), which imposes specific data protection duties on entities that collect and process genetic data for personal ancestry or health purposes.
Core Legal Theories in the Genetic Data Lawsuit:
- Negligence in data security relative to the sensitivity of genetic information
- Violation of the California Genetic Information Privacy Act (GIPA)
- Violation of the California Consumer Privacy Act (CCPA)
- Breach of implied contract (privacy policy representations)
- Delayed breach notification
*Attorney Insight: Attorneys handling these claims note that the GIPA theory is particularly significant because it creates statutory damages without requiring proof of actual harm, which substantially expands the potential recovery pool for class members whose genetic data was exposed even without documented downstream consequences.*
Why the 23andMe California Lawsuit Carries Extra Legal Weight
The 23andMe California lawsuit carries legal weight beyond most data breach cases because California's Genetic Information Privacy Act imposes heightened duties and statutory penalties specific to genetic data.
California's GIPA requires companies that collect genetic data to obtain express written consent before using, sharing, or monetizing that data. It also imposes security standards above general consumer data protection requirements. Violations can trigger statutory damages per affected consumer, independent of whether any individual can prove concrete financial harm.
This is the mechanism that gave plaintiffs significant leverage in settlement negotiations. The threat of GIPA statutory damages for 6.9 million class members produced a negotiating posture that a standard negligence-only case would not have achieved.
California Law Framework Relevant to This Case:
| Law | Relevance |
|---|---|
| Genetic Information Privacy Act (GIPA) | Core liability theory; statutory damages for genetic data mishandling |
| California Consumer Privacy Act (CCPA) | Secondary theory; consumer data rights and breach notification duties |
| California Confidentiality of Medical Information Act (CMIA) | Potentially applicable to health predisposition data |
| Common law negligence | Standard duty-of-care framework applied to security practices |
*Attorney Insight: Attorneys handling these claims point to GIPA's per-consumer statutory damages provision as a significant litigation asset that distinguished the 23andMe case from generic credential-stuffing breach actions.*
What Is the 23andMe Settlement Claim Deadline?
The 23andMe settlement claim deadline is a court-ordered cutoff after which new claims cannot be submitted and claimants forfeit their right to participate in any distribution.
As of the information available through early 2026, the claims deadline is subject to adjustment pending the bankruptcy court's resolution of the trust-status issue. The original deadline established in the Northern District of California settlement approval order has been subject to administrative extension while bankruptcy proceedings continue in Delaware.
Claimants should not assume extensions will continue indefinitely. Courts do not grant unlimited delay, and once a final distribution order is entered, latecomers receive nothing.
Deadline Guidance for 2026:
- Check the official court-appointed settlement administrator's portal for the operative deadline
- Bankruptcy-related extensions are temporary and not guaranteed to continue
- Submitting a claim before any deadline, even an extended one, is always preferable to waiting
- A submitted claim preserves your position; an unsubmitted claim forfeits it
*Attorney Insight: Attorneys handling these claims consistently report that claimants who waited for "more clarity" on the bankruptcy situation and missed the claim deadline lost all recovery rights, even if the trust-segregation argument ultimately prevailed.*
Litigation Watch: Extensions tied to bankruptcy proceedings give 2026 claimants more time than the original schedule allowed, but that window is not unlimited. Filing now rather than later protects the position.
How to File a 23andMe Claim in 2026
Filing a 23andMe claim in 2026 requires submitting a completed claim form through the court-approved settlement administrator, along with any documentation supporting a higher tier designation.
The process has several sequential steps. The claims administrator verifies class membership by cross-referencing submitted information against 23andMe's breach notification records. Valid claims are then tier-assigned based on documentation review.
Step-by-Step Filing Process:
- Locate the official settlement administrator portal designated by the N.D. Cal. court order
- Confirm your identity and account information match 23andMe records
- Complete the standard claim form with full personal information
- Select the compensation tier you believe applies to your harm
- Upload all supporting documentation for Tier 2 or Tier 3 claims
- Submit and retain your confirmation number
- Monitor the administrator portal for status updates
Documents to gather before filing:
- Breach notification email or letter from 23andMe
- Any fraud alerts, credit monitoring reports, or identity theft documentation
- Bank or credit card records showing unauthorized activity traceable to the breach
- Medical or professional records documenting harm from genetic data exposure (Tier 3)
*Attorney Insight: Attorneys handling these claims note that claimants who consult with counsel before filing a Tier 2 or Tier 3 claim consistently produce stronger documentation packages, which materially affects tier assignment and final payout.*
Can You Get a 23andMe Personal Injury Payout?
A personal injury payout from the 23andMe litigation is possible but requires navigating both the class action settlement framework and potentially a separate individual legal action.
The class action settlement is the primary vehicle for compensation. Within that framework, Tier 3 claimants are the closest analog to personal injury recovery, because they must demonstrate specific, documented harm beyond the mere exposure of data.
Some claimants with extraordinary documented harm from genetic data exposure have pursued or explored individual opt-out claims rather than participating in the class settlement. An opt-out claimant forfeits their right to the class settlement but preserves the ability to sue 23andMe independently for greater damages. The company's bankruptcy filing significantly complicates opt-out strategies, because individual lawsuits against a debtor in bankruptcy are automatically stayed under the bankruptcy code.
Personal Injury Recovery Options Compared:
| Option | Recovery Potential | Complexity | Bankruptcy Risk |
|---|---|---|---|
| Tier 1 class claim | $100 to $200 | Low | Moderate (trust dispute) |
| Tier 3 class claim | Up to $10,000 | Moderate | Moderate (trust dispute) |
| Individual opt-out suit | Theoretically higher | High | High (automatic stay) |
*Attorney Insight: Attorneys handling these claims strongly advise that individual opt-out strategies in the context of a Chapter 11 debtor are rarely worth pursuing without specific counsel, because the automatic stay effectively freezes independent actions and recovery timelines become unpredictable.*
What Is the 23andMe Settlement Distribution Timeline?
The 23andMe settlement distribution timeline is not fixed in 2026 because the bankruptcy court proceedings in Delaware have introduced scheduling uncertainty that the Northern District of California settlement order alone cannot resolve.
Under a standard non-bankruptcy class action settlement, distribution typically occurs 60 to 120 days after the claims deadline passes and the administrator completes verification. That timeline is materially extended here.
The operative sequence for 2026 distribution is:
- Delaware bankruptcy court rules on trust-segregation status
- If the fund is confirmed as a separate trust, the N.D. Cal. court enters a final distribution order
- Claims administrator processes verified claims and generates payment files
- Payments issue via check or electronic transfer per claimant preference
- Uncashed checks and undeliverable funds are handled under the cy-pres provisions of the settlement
Projected Timeline Milestones:
| Milestone | Projected Timeframe |
|---|---|
| Delaware bankruptcy trust ruling | Mid-2026 |
| N.D. Cal. final distribution order | Third quarter 2026 (if trust ruling is favorable) |
| Payment issuance | Fourth quarter 2026 (best-case scenario) |
| Cy-pres distribution of residual funds | 2027 |
*Attorney Insight: Attorneys handling these claims note that "best-case scenario" language is intentional here. Multiple intervening events, including appeals of the bankruptcy court ruling, could push distribution into 2027.*
What Type of Attorney Handles 23andMe Claims?
The type of attorney who handles 23andMe claims is typically a class action litigator with experience in data privacy, consumer protection, or technology-related mass tort cases.
For most claimants filing under Tier 1, hiring individual counsel is not economically necessary. The claims process is administrative, and class counsel already represents the class. Attorney fees in that context are handled through the court-approved fee petition out of the settlement fund.
For Tier 2 and Tier 3 claimants, individual counsel can add significant value. A data privacy attorney can help document harm, structure the claim submission, and assess whether the class settlement represents the best available recovery or whether an alternative strategy is viable.
Attorney Types by Claim Situation:
| Situation | Recommended Attorney Type |
|---|---|
| Standard Tier 1 claim | No individual attorney needed; class counsel handles |
| Tier 2 documented harm claim | Data privacy or consumer protection attorney |
| Tier 3 genetic data harm claim | Data privacy attorney with genetic information law experience |
| Opt-out individual suit | Class action plaintiff's attorney with bankruptcy litigation experience |
| Disputed claim by administrator | Consumer protection or class action appeals counsel |
*Attorney Insight: Attorneys handling these claims point out that California-based data privacy attorneys with GIPA litigation experience are the most specifically suited counsel for elevated claims, given that California law is the primary liability framework governing this settlement.*
Litigation Watch: Consulting an attorney is most valuable for Tier 2 and Tier 3 claimants before submission, not after, because post-submission documentation supplementation is typically not permitted under the settlement administration protocol.
A Brief History of the 23andMe Data Breach Class Action
The 23andMe data breach class action has its origins in a cyberattack discovered in October 2023, when the company's security team identified that customer accounts had been accessed using credential-stuffing techniques.
Initial lawsuits were filed in federal court within weeks of the public disclosure. By early 2024, dozens of individual cases had been consolidated into the multi-plaintiff class action docketed as Case No. 3:23-cv-01130-AMO in the Northern District of California before Judge Araceli Martinez-Olguin. The consolidation brought together plaintiffs from across the country under a unified litigation framework.
Settlement negotiations proceeded through 2024, resulting in the $30 million agreement. In March 2025, 23andMe filed for Chapter 11 bankruptcy, fundamentally altering the legal landscape. The company's CEO and co-founder Anne Wojcicki had explored various sale and restructuring options before the bankruptcy petition was ultimately filed.
Key Historical Milestones:
| Date | Event |
|---|---|
| October 2023 | 23andMe discovers and discloses the data breach |
| October to December 2023 | Initial class action lawsuits filed in N.D. Cal. and elsewhere |
| Early 2024 | Cases consolidated under Case No. 3:23-cv-01130-AMO |
| 2024 | Settlement negotiations; $30 million agreement reached |
| March 2025 | 23andMe files Chapter 11, Case No. 25-10074, D. Del. |
| 2025 to 2026 | Bankruptcy court proceedings; settlement trust status contested |
| 2026 | Distribution timeline contingent on Delaware court ruling |
*Attorney Insight: Attorneys handling these claims note that the sequence of settlement approval before the bankruptcy filing is a critical factual and legal asset for class members, because it establishes that the settlement obligation predates the bankruptcy petition.*
Frequently Asked Questions
How much money will I get from the 23andMe settlement?
The amount depends on your assigned tier.
Tier 1 claimants, who make up the vast majority of the class, are projected to receive approximately $100 to $200.
Tier 2 claimants with documented harm may receive $1,000 to $5,000, and Tier 3 claimants can potentially recover up to $10,000.
Do I need to prove harm to qualify for the 23andMe settlement?
No proof of harm is required to qualify at the base level.
Any U.S. customer who received a breach notification from 23andMe qualifies for Tier 1 participation by filing a claim form.
Proving documented harm is required only to access the higher-tier payout categories.
What happens to my settlement claim if 23andMe filed for bankruptcy?
Your claim is not automatically extinguished by the bankruptcy filing.
Class counsel has argued in the U.S. Bankruptcy Court for the District of Delaware that the $30 million settlement fund is a separate trust, shielded from bankruptcy estate treatment.
If that argument prevails, claimants receive their projected distributions. If it fails, recovery may be reduced.
Is there still time to file a 23andMe claim in 2026?
Filing deadlines have been administratively extended in connection with bankruptcy proceedings, but those extensions have limits.
Check the official court-appointed settlement administrator's portal for the current operative deadline.
Filing as soon as possible is the only reliable way to preserve your position in the distribution.
What kind of lawyer should I contact about the 23andMe lawsuit?
For Tier 1 claims, no individual attorney is necessary.
For Tier 2 or Tier 3 claims, a data privacy or consumer protection attorney with class action experience is the appropriate choice.
California-licensed attorneys familiar with the Genetic Information Privacy Act are best suited for claims involving health predisposition or raw genetic data exposure.
Does the settlement cover my genetic and health data, not just my email?
Yes, the settlement specifically covers the exposure of genetic ancestry data, health predisposition results, and raw genotype files.
The legal framework under California's Genetic Information Privacy Act was built specifically to address the heightened sensitivity of that data category.
Claimants whose health predisposition data was among the exposed information have the strongest basis for Tier 2 and Tier 3 designation.
What Comes Next for 23andMe Claimants
The $30 million settlement is real. The legal complexity surrounding it is equally real. Claimants who filed valid claims before the deadline have preserved their position. Those who have not yet filed should act before the next administrative cutoff.
The bankruptcy court ruling in Delaware is the event that controls everything downstream. Once that ruling issues, the distribution sequence will move. Claimants with Tier 2 or Tier 3 documentation should speak with a data privacy attorney before that ruling, not after.
This case is not over, and it is not simple. The legal machinery is still running.
